Inicio/Acciones/SXTP

SXTP

USD

60 Degrees Pharmaceuticals Inc. Common Stock

$1.230+0.000 (0.000%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.230

Máximo

$1.269

Mínimo

$1.180

Volumen

0.12M

Fundamentos de la Empresa

Capitalización de Mercado

5.0M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.14M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.18Actual $1.230Máximo $12.45

Noticias Relacionadas

15 oct 2025 · 11:14

GlobeNewswire

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA)Results obtained using

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

9 oct 2025 · 11:04

GlobeNewswire

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study

Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competitionA $5K donation from the Company was split between ILADEF and GLA to recognize the winning nameB-FREE, a Phase